Description
Rethinking the reimbursement of innovative medicines in oncology: Looking beyond overall survival
Article: Rethinking the reimbursement of innovative medicines in oncology: Looking beyond overall survival
€3.03
Related products
-
Article: Highlights in melanoma
€3.03 Add to cart -
Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer
€3.03 Add to cart -
Article: Highlights in respiratory oncology
€3.03 Add to cart -
Article: Highlights in squamous cell carcinoma of the head and neck
€3.03 Add to cart
